P1/2, N=31, Terminated, Nerviano Medical Sciences | Completed --> Terminated; In the Phase II part of the study, among the participants evaluable for efficacy, no objective (partial response or clinical response) was observed at the first futility analysis.

7 months ago

Trial termination

NMS-153

over1year

Study on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma (HCC) Previously Treated With Systemic Therapy (clinicaltrials.gov)

P1/2, N=31, Completed, Nerviano Medical Sciences | Active, not recruiting --> Completed | Trial completion date: Mar 2025 --> Aug 2024

over 1 year ago

Trial completion • Trial completion date

NMS-153

almost2years

Study on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma (HCC) Previously Treated With Systemic Therapy (clinicaltrials.gov)

P1/2, N=31, Active, not recruiting, Nerviano Medical Sciences | Recruiting --> Active, not recruiting | N=57 --> 31 | Trial completion date: Mar 2026 --> Mar 2025 | Trial primary completion date: Nov 2025 --> Jan 2024

almost 2 years ago

Enrollment closed • Enrollment change • Trial completion date • Trial primary completion date

NMS-153

over2years

Study on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma (HCC) Previously Treated With Systemic Therapy (clinicaltrials.gov)

P1/2, N=57, Recruiting, Nerviano Medical Sciences | Trial completion date: Mar 2027 --> Mar 2026 | Trial primary completion date: Nov 2026 --> Nov 2025

over 2 years ago

Trial completion date • Trial primary completion date

NMS-153